Chou KC - Search Results

1

Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide.

Du QS, Wang SQ, Zhu Y, Wei DQ, Guo H, Sirois S, Chou KC. Du QS, et al. Among authors: chou kc. Peptides. 2004 Nov;25(11):1857-64. doi: 10.1016/j.peptides.2004.06.018. Peptides. 2004. PMID: 15501516 Free PMC article.

2

Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.

Du Q, Wang S, Jiang Z, Gao W, Li Y, Wei D, Chou KC. Du Q, et al. Among authors: chou kc. Med Chem. 2005 May;1(3):209-13. doi: 10.2174/1573406053765468. Med Chem. 2005. PMID: 16787316

3

Molecular modeling studies of peptide drug candidates against SARS.

Zhang R, Wei DQ, Du QS, Chou KC. Zhang R, et al. Among authors: chou kc. Med Chem. 2006 May;2(3):309-14. doi: 10.2174/157340606776930736. Med Chem. 2006. PMID: 16948478

4

Inhibitor design for SARS coronavirus main protease based on "distorted key theory".

Du QS, Sun H, Chou KC. Du QS, et al. Among authors: chou kc. Med Chem. 2007 Jan;3(1):1-6. doi: 10.2174/157340607779317616. Med Chem. 2007. PMID: 17266617

5

Correlations of amino acids in proteins.

Du Q, Wei D, Chou KC. Du Q, et al. Among authors: chou kc. Peptides. 2003 Dec;24(12):1863-9. doi: 10.1016/j.peptides.2003.10.012. Peptides. 2003. PMID: 15127938

6

Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase.

Du Q, Wang S, Wei D, Sirois S, Chou KC. Du Q, et al. Among authors: chou kc. Anal Biochem. 2005 Feb 15;337(2):262-70. doi: 10.1016/j.ab.2004.10.003. Anal Biochem. 2005. PMID: 15691506 Free PMC article.

7

Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives.

Wei DQ, Sirois S, Du QS, Arias HR, Chou KC. Wei DQ, et al. Among authors: chou kc. Biochem Biophys Res Commun. 2005 Dec 16;338(2):1059-64. doi: 10.1016/j.bbrc.2005.10.047. Epub 2005 Oct 21. Biochem Biophys Res Commun. 2005. PMID: 16256952

8

Progress in computational approach to drug development against SARS.

Chou KC, Wei DQ, Du QS, Sirois S, Zhong WZ. Chou KC, et al. Curr Med Chem. 2006;13(27):3263-70. doi: 10.2174/092986706778773077. Curr Med Chem. 2006. PMID: 17168850 Review.

9

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

Chou KC, Wei DQ, Zhong WZ. Chou KC, et al. Biochem Biophys Res Commun. 2003 Aug 15;308(1):148-51. doi: 10.1016/s0006-291x(03)01342-1. Biochem Biophys Res Commun. 2003. PMID: 12890493 Free PMC article.

10

Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points.

Sirois S, Wei DQ, Du Q, Chou KC. Sirois S, et al. Among authors: chou kc. J Chem Inf Comput Sci. 2004 May-Jun;44(3):1111-22. doi: 10.1021/ci034270n. J Chem Inf Comput Sci. 2004. PMID: 15154780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters